Table 1 Cell cycle distribution in ovarian cancer and normal cells treated with PBS, Ad-luc or Ad-mda7
From: MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo
| Â | MDAH 2774 (%) | OVCA 420 (%) | IOSE 80 (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | G1 | S | G2M | G1 | S | G2M | G1 | S | G2M |
PBS | 72.2 ± 10.5 | 20.4 ± 9.3 | 7.3 ± 1.5 | 68.2 ± 4.9 | 21.7 ± 5.2 | 10.0 ± 1.6 | 40.2 ± 1.4 | 42.0 ± 2.6 | 18.0 ± 1.6 |
Ad-Luc | 52.5 ± 6.2 | 25.2 ± 3.0 | 22.2 ± 3.3 | 68.2 ± 6.3 | 13.1 ± 2.3 | 18.2 ± 4.6 | 55.3 ± 2.2 | 26.3 ± 1.2 | 19.0 ± 1.5 |
Ad-mda7 | 243 ± 38 | 27.0 ± 14.6 | 50.2 ± 16.4 | 57.0 ± 4.8 | 14.4 ± 2.4 | 29.0 ± 4.2 | 48.8 ± 3.6 | 28.6 ± 2.1 | 23.0 ± 2.5 |